Table 1.

Haplotypes of cytomegalovirus-positive donors and T-cell receptor structure of T-cell clones isolated from peripheral blood mononuclear cells evaluated by in vitro stimulation

DonorHLA-A1HLA-A2HLA-B1HLA-B2TCCTCRATCRB
AA A2 A2 B44 B60    
BS A2 A26 B51 B62 BS25 AV2S1A2-AJ45-AC BV7S2A1-BJ2.1-BC2 
CM A2 A3 B7 B14    
GL A2 A68 B51 B60 3-3F4 AV18S2-AJ17.3-AC BV13S1-BJ1.2-BC1 
JE A2 A68 B7 B17    
KKM A2 A1 B27 B44    
LV A2 A2 B51 B55 LVB ND ND 
NO A2 A3 B47 B51 — — — 
RB A2 A2 B52 B60 — — — 
TG A2 A68 B62 B62 TGA2 AV3S1-AJ9.12-AC BV13S2A1-BJ2.1-BC2 
VB A2 A3 B44 B62 VB57 AV18S1-AJ20-AC BV20S1A3-BJ1.1-BC1 
DonorHLA-A1HLA-A2HLA-B1HLA-B2TCCTCRATCRB
AA A2 A2 B44 B60    
BS A2 A26 B51 B62 BS25 AV2S1A2-AJ45-AC BV7S2A1-BJ2.1-BC2 
CM A2 A3 B7 B14    
GL A2 A68 B51 B60 3-3F4 AV18S2-AJ17.3-AC BV13S1-BJ1.2-BC1 
JE A2 A68 B7 B17    
KKM A2 A1 B27 B44    
LV A2 A2 B51 B55 LVB ND ND 
NO A2 A3 B47 B51 — — — 
RB A2 A2 B52 B60 — — — 
TG A2 A68 B62 B62 TGA2 AV3S1-AJ9.12-AC BV13S2A1-BJ2.1-BC2 
VB A2 A3 B44 B62 VB57 AV18S1-AJ20-AC BV20S1A3-BJ1.1-BC1 

Peripheral blood and skin biopsy specimens were obtained after individual consent and according to the provisions of the City of Hope Institutional Review Board. Individuals were first screened by known HLA type (per the City of Hope or National Marrow Donor program) and were checked for CMV seropositivity by indirect immunofluorescence (Hemagen Diagnostic, Columbia, MD) at the City of Hope Clinical Microbiology Laboratory. Both HLA alleles are shown for each individual as determined by serologic analysis using microcytotoxicity assay. TCCs were isolated from IVS cultures of selected donors, and theTCR gene structure was identified by PCR and DNA sequencing as described in “Materials and methods.”

HLA indicates human leukocyte antigen; TCC, T-cell clone; TCR, T-cell receptor; CMV, cytomegalovirus; ND not determined; PCR, polymerase chain reaction.

or Create an Account

Close Modal
Close Modal